Sam Forman, MD, MPH, MSOccH, MBA, FACOEM
Dr. Forman is president of Oak and Ivy Health Systems, a consulting firm encompassing health-related business strategy, chronic disease management, clinical quality improvement, business investments, and applied toxicology issues.
Dr. Forman holds medically related degrees from Cornell and Harvard. A graduate of the Yale School of Management, he was instrumental in creating their annual health sector colloquia beginning with Healthcare 2005.
In the context of the Initiative for Productivity and Health management (IPHM) he is integrating modern approaches to the health benefits of commercial populations with the traditional employee health curriculum, and building a platform for internal and external authorities in the field to pursue directed research, share best practices and achieve results.
Following leadership positions in the United States Navy, Procter and Gamble, Yale School of Management, and Blue Cross Blue Shield, Dr. Forman was the co-founder and Chief Medical Officer of StatusOne Health Systems (1997-2004). Status One’s innovations combined predictive modeling, intranet software, nursing services as well as financial and clinical performance measurements in caring for high-risk workers and their dependents, as well as for Medicare beneficiary populations. He is the author of Status One –Breakthroughs in High Risk Population Health Management. StatusOne was acquired by Healthways, Inc., a company that has fully integrated Status One’s products, services and employees.
Dr. Forman is currently the President of Oak and Ivy Health Systems, Inc.. He is writing a biography of Joseph Warren, the Revolutionary War-era political activist, physician, Harvard alumnus, and warrior.
Coberley C, Hamar B, Gandy B, Orr P, Coberley S, McGinnis M, Hudson L, Forman S, Shurney D, Pope J: “Impact of Telephonic Interventions on Glycosylated Hemoglobin and Low-density Lipoprotein Cholesterol Testing” Am J Managed Care 13(4): 188-192, 2007.
Forman S: “Targeting the Highest Risk Population to Complement Disease Management” Health Management Technology 49-50, Jul 2004.
Forman SA, Lynch JP: “High Risk Geriatric Population Management” J Am Geriatric Assoc S111, May 2001.
Lynch J, Forman SA, Graff S, Gunby M: “High Risk Population Health Management: Achieving Improved Patient Outcomes and Near-Term Financial Results” Am J Managed Care 6(7):781-791, 2000.
Forman S: “Medicare Risk Plans and Disease Management Vendors” Disease Management and Health Outcomes 7(1):1-4, 2000.
(Book) Forman SA, Kelliher M: Status One: Breakthroughs in High Risk Population Health Management, Medical Management Series, Jossey Bass Publishers, San Francisco 1999.
Borron SW, Forman SA, Lockey JE, Lemasters GK, Yee LM: “Dust and Mirrors or Corruption is in the Eye of the Beholder,” American Journal of Industrial Medicine 34:409-410, 1998.
Forman SA, Kelliher M, Wood G: “Clinical Improvement with Bottom Line Impact – Custom Care Planning for the Acutely, Chronically Ill in a Managed Care Setting,” J Managed Care 3(7): 1039-1048, July 1997.
Borron SW, Forman, SA, Lockey JE, Lemasters GK, Yee LM: “An Unpublished 1932 Study of Asbestosis Among Manufacturing Workers: Reconstruction of the Cohort and Original Findings,” American Journal of Industrial Medicine 31: 324-334, 1997.
Ducatman AM, Forman SA, Teichman R, Gleason RE: “Occupational Physician Staffing in Large U.S. Corporations,” Journal of Occupational Medicine 33(5): 613-618, 1991.
Forman SA: “A Review of Propylene Glycol Dinitarate Toxicology and Epidemiology,” Toxicology Letters 43: 51-65, 1988.
Ducatman AM, Yang WM, Forman SA: “B-Readers and Asbestos Medical Surveillance,” Journal of Occupational Medicine 30(8): 644-647, 1988.